CURE Pharmaceutical begins 2019 on a high note

We report significant activity this quarter, setting the pace for a strong start to 2019. Clinical planning has commenced for our CUREfilm Blue™ (Sildenafil 50mg) product on the heels of a pre-IND meeting with the FDA in March. We recently announced our planned acquisition of Chemistry Holdings which will bring novel and complementary formulation technology…